A strategic alliance between WellPoint Inc and Resolution Health Inc (RHI) aims to improve patient compliance with care recommendations and lower out-ofpocket expenses. The goal will be achieved through personalized communication that allows patients to take better control of their health and health care decision making.
WellPoint will use RHI's proprietary technology and >1000 computer algorithms to find new opportunities to help close the gap between care that is recommended based on nationally accepted, evidence-based clinical guidelinesand care that beneficiaries truly receive. Furthermore, RHI tools will be used to inform patients about the out-of-pocket cost savings by making more informed health care decisions.
Using its data-analytic capabilities, RHI will assess WellPoint's patients'medical and pharmacy claims data, laboratory results, and information that members provide through on-line health assessments and personal health records. These analyses will become the foundation for customized communication programs that target both patients and their physicians.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs